CAS: 17341-25-2; Sodium(1+)

上下游产品

CAS号7440-23-5 钠标准溶液 | CAS号7647-14-5 氯化钠 | CAS号497-19-8 纯碱 | CAS号7681-82-5 碘化钠 | CAS号7782-49-2 硒 | CAS号7757-83-7 无水亚硫酸钠 | CAS号7782-82-3 亚硒酸氢钠 | CAS号7732-18-5 水 | CAS号7782-50-5 氯气 | CAS号497-19-8 纯碱 | CAS号7440-23-5 钠标准溶液 | CAS号1333-74-0 氢 | CAS号7631-99-4 硝酸钠 | CAS号124-43-6 过氧化脲 | CAS号7681-52-9 次氯酸钠 | CAS号10049-21-5 磷酸二氢钠单水合物 | CAS号144-55-8 碳酸氢钠 | CAS号141-53-7 甲酸钠

专利信息

专利号:US-9206209-B2
优先权日:2010-10-19
标 题:Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition
发明人：KRASZEWSKI ADAM; ROMANOWSKA JOANNA; SOBKOWSKI MICHAL; SZYMANSKA-MICHALAK AGNIESZKA; STAWINSKI JACEK; BORYSKI JERZY; LIPNIACKI ANDRZEJ; PIASEK ANDRZEJ
权利人:KRASZEWSKI ADAM; ROMANOWSKA JOANNA; SOBKOWSKI MICHAL; SZYMANSKA-MICHALAK AGNIESZKA; STAWINSKI JACEK; BORYSKI JERZY; LIPNIACKI ANDRZEJ; PIASEK ANDRZEJ; INST CHEMII BIOORG PAN; NARODOWY INST LEKOW
摘要:An exemplary emboidment is related to a pharmaceutical composition of the class of nucleotide analogues and antiviral pro-nucleotides useful in partial or complete inhibition of human immunodeficiency virus (HIV). An exemplary embodiment is expressed in the formula (XVI): n nwhere X stands for N 3 and B stands for thymidine-1-yl, or X stands for H and B stands for uracil-1-yl or adenin-1-yl or hypoxanthin-1-yl.A method of synthesis of the nucleotide analogue using a phosphorylating agent for synthesis of the nucleotide analogue is provided.

专利号:US-2010087658-A1
优先权日:1996-08-06
标 题 :Methods and intermediates for synthesis of selective dpp-iv inhibitors
发明人：CAMPBELL DAVID ALAN; LEITAO EMILIA P T; WU ZHEN-PING; WANG PENG
权利人:PHENOMIX CORP
摘要:Methods and intermediates for the synthesis of selective inhibitors of dipeptidyl peptidase IV (DPP-IV) are provided. Coupling of a carboxylate salt with a boro-proline derivative provides a protected form of a DPP-IV inhibitor, which may be deblocked to yield the medicinal compound. The carboxylate salt can be a crystalline form of a sodium salt or a dicyclohexylammonium salt. The inhibitor can be used in the treatment of diabetes.

专利号:US-4818816-A
优先权日:1981-04-28
标 题:Process for the organic synthesis of oligosaccharides and derivatives thereof
发明人：PETITOU MAURICE; JACQUINET JEAN-CLAUDE; SINAY PIERRE; CHOAY JEAN; LORMEAU JEAN-CLAUDE; NASSR MAHMOUD
权利人:CHOAY SA
摘要:The invention relates to a process for the organic synthesis of oligosaccharides constituting or comprising fragments of acid mucopolysaccharides comprising the reaction of two compounds constituted or terminated by units of glucosamine structure and of uronic acid structure respectively, said units being specifically substituted. This process particularly enables valuable anticoagulant drugs to be obtained.

专利号:US-2007128509-A1
优先权日:2005-12-05
标 题:Producing sodium borohydride with high energy efficiency and recycles of by-product materials
发明人：HONG ZONGXUAN
权利人:HONG ZONGXUAN
摘要:A method for synthesizing sodium borohydride compound with reduced energy usage and recycles of by-product materials involved in the application and synthesis processes of sodium borohydride is disclosed. The method utilizes a sodium-sulfur electrochemical cell flow system for synthesizing sodium metal and incorporates the sodium metal produced in the commercial sodium borohydride synthesis processes known in prior arts, for example, the “Schlesinger processâ€?. Furthermore, the by-product materials involved in the application and synthesis of sodium borohydride are recycled through a series of processes.

专利号:US-2021369846-A1
优先权日:2018-10-26
标 题 :New Ammonium Salts Of Fluorinated Organic Acids, Method Of Their Synthesis and Application
发明人：STEFANEK AGATA; CIACH TOMASZ; LECZYCKAWILK KATARZYNA; CZARNOCKA-SNIADALA SYLWIA; GRAFSTEIN JOANNA; DRESLER MAGDALENA; NOWAK ALEKSANDRA; WGLINKSKI JAKUB
权利人:NANOSANGUIS
摘要:The exemplary arrangements relate to ammonium salts of partially fluorinated organic acids. The exemplary arrangements also relate to methods of synthesis of the ammonium salts of partially fluorinated organic acids. The exemplary arrangements also relate to methods of use of the ammonium salts of partially fluorinated organic acids to produce stabilizing emulsions of the oil-in-water and/or water-in-oil type. The exemplary arrangements also relate to methods of use and applications of the ammonium salts of partially fluorinated organic acids, for example use as stabilizing agents in blood substitute preparations.

专利号:US-6596256-B1
优先权日:2000-08-28
标 题:Synthesis of low silicon sodium X zeolite
发明人：OJO ADEOLA F; FITCH FRANK R; BUELOW MARTIN; GITTLEMAN CRAIG S; JALE SUDHAKAR R
权利人:BOC GROUP INC
摘要:Low silicon sodium X zeolite containing little or no sodium A zeolite as by-product, is prepared by direct synthesis from sodium ion-containing hydrogels, the crystallization step being carried out by maintaining the hydrogels at a temperature below about 70° C., and preferably in the range of about 50 to about 70° C. for the duration of the crystallization step. Preferably, the ratios of components in the solutions used to make the hydrogel are such that in the hydrogel the silica/alumina molar ratio will be in the range of about 2.25:1 to about 2.4:1; the sodium oxide to silica molar ratio will be in the range 1.6:1 to about 1.9:1; and the water to sodium oxide molar ratio will be greater than about 60:1.